Annual Gross Margin
62.53%
-13.97%-18.26%
31 December 2023
Summary:
Nektar Therapeutics annual gross profit margin is currently 62.53%, with the most recent change of -13.97% (-18.26%) on 31 December 2023. During the last 3 years, it has fallen by -24.73% (-28.34%). NKTR annual gross margin is now -52.75% below its all-time high of 132.35%, reached on 31 December 1995.NKTR Gross Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Gross Margin
81.62%
+23.09%+39.45%
30 September 2024
Summary:
Nektar Therapeutics quarterly gross profit margin is currently 81.62%, with the most recent change of +23.09% (+39.45%) on 30 September 2024. Over the past year, it has increased by +33.11% (+68.25%). NKTR quarterly gross margin is now -90.05% below its all-time high of 820.00%, reached on 31 December 1994.NKTR Quarterly Gross Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NKTR Gross Margin Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -18.3% | +68.3% |
| 3 y3 years | -28.3% | +3.7% |
| 5 y5 years | -36.2% | -1.8% |
NKTR Gross Margin High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -28.3% | at low | at high | +68.3% |
| 5 y | 5 years | -36.2% | at low | -11.7% | +68.3% |
| alltime | all time | -52.8% | +36.6% | -90.0% | +135.0% |
Nektar Therapeutics Gross Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | 81.62%(+39.4%) |
| June 2024 | - | 58.53%(-3.4%) |
| Mar 2024 | - | 60.56%(-12.9%) |
| Dec 2023 | 62.53%(-18.3%) | 69.51%(+43.3%) |
| Sept 2023 | - | 48.51%(-26.4%) |
| June 2023 | - | 65.88%(-2.1%) |
| Mar 2023 | - | 67.31%(-6.1%) |
| Dec 2022 | 76.50%(+1.2%) | 71.70%(-9.2%) |
| Sept 2022 | - | 78.95%(+3.5%) |
| June 2022 | - | 76.30%(-2.9%) |
| Mar 2022 | - | 78.59%(+4.3%) |
| Dec 2021 | 75.57%(-13.4%) | 75.36%(-4.2%) |
| Sept 2021 | - | 78.69%(+7.9%) |
| June 2021 | - | 72.94%(-3.6%) |
| Mar 2021 | - | 75.66%(-7.2%) |
| Dec 2020 | 87.26%(+7.3%) | 81.57%(+0.1%) |
| Sept 2020 | - | 81.45%(-7.6%) |
| June 2020 | - | 88.18%(-4.6%) |
| Mar 2020 | - | 92.46%(+12.3%) |
| Dec 2019 | 81.35%(-16.9%) | 82.31%(-1.0%) |
| Sept 2019 | - | 83.14%(+5.9%) |
| June 2019 | - | 78.48%(-2.8%) |
| Mar 2019 | - | 80.72%(-0.7%) |
| Dec 2018 | 97.95%(+8.7%) | 81.27%(-1.8%) |
| Sept 2018 | - | 82.77%(-16.8%) |
| June 2018 | - | 99.49%(+20.6%) |
| Mar 2018 | - | 82.52%(-8.1%) |
| Dec 2017 | 90.07%(+10.2%) | 89.78%(-6.8%) |
| Sept 2017 | - | 96.29%(+30.1%) |
| June 2017 | - | 74.01%(-1.6%) |
| Mar 2017 | - | 75.21%(-8.7%) |
| Dec 2016 | 81.74%(-4.1%) | 82.37%(+2.1%) |
| Sept 2016 | - | 80.64%(+5.4%) |
| June 2016 | - | 76.48%(-10.0%) |
| Mar 2016 | - | 84.94%(+7.8%) |
| Dec 2015 | 85.22%(-0.7%) | 78.76%(-11.2%) |
| Sept 2015 | - | 88.72%(+65.8%) |
| June 2015 | - | 53.51%(-42.0%) |
| Mar 2015 | - | 92.24%(+36.1%) |
| Dec 2014 | 85.78%(+15.7%) | 67.79%(-27.2%) |
| Sept 2014 | - | 93.06%(+13.4%) |
| June 2014 | - | 82.09%(+36.8%) |
| Mar 2014 | - | 60.01%(-15.8%) |
| Dec 2013 | 74.14%(+18.6%) | 71.23%(-9.7%) |
| Sept 2013 | - | 78.86%(-7.4%) |
| June 2013 | - | 85.20%(+72.8%) |
| Mar 2013 | - | 49.31%(-24.8%) |
| Dec 2012 | 62.52% | 65.53%(+7.9%) |
| Sept 2012 | - | 60.74%(-12.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2012 | - | 69.59%(+35.2%) |
| Mar 2012 | - | 51.49%(-21.4%) |
| Dec 2011 | 69.37%(-17.3%) | 65.47%(-19.6%) |
| Sept 2011 | - | 81.39%(+53.5%) |
| June 2011 | - | 53.03%(-25.4%) |
| Mar 2011 | - | 71.12%(-8.1%) |
| Dec 2010 | 83.86%(+47.2%) | 77.41%(-7.3%) |
| Sept 2010 | - | 83.53%(-5.6%) |
| June 2010 | - | 88.51%(+1.7%) |
| Mar 2010 | - | 87.07%(+12.5%) |
| Dec 2009 | 56.98%(-6.8%) | 77.42%(+93.5%) |
| Sept 2009 | - | 40.00%(+99.1%) |
| June 2009 | - | 20.09%(-52.2%) |
| Mar 2009 | - | 42.07%(-34.3%) |
| Dec 2008 | 61.15%(+33.0%) | 64.04%(-14.7%) |
| Sept 2008 | - | 75.05%(+13.7%) |
| June 2008 | - | 66.03%(+77.7%) |
| Mar 2008 | - | 37.16%(-41.4%) |
| Dec 2007 | 45.97%(+0.5%) | 63.44%(+23.8%) |
| Sept 2007 | - | 51.25%(+27.8%) |
| June 2007 | - | 40.09%(+19.6%) |
| Mar 2007 | - | 33.52%(-18.5%) |
| Dec 2006 | 45.76%(-43.7%) | 41.15%(-12.1%) |
| Sept 2006 | - | 46.82%(+20.2%) |
| June 2006 | - | 38.94%(-43.5%) |
| Mar 2006 | - | 68.94%(-33.3%) |
| Dec 2005 | 81.21%(-1.8%) | 103.41%(+38.5%) |
| Sept 2005 | - | 74.69%(+4.3%) |
| June 2005 | - | 71.63%(-2.6%) |
| Mar 2005 | - | 73.51%(-8.9%) |
| Dec 2004 | 82.67%(-4.1%) | 80.71%(-4.3%) |
| Sept 2004 | - | 84.32%(+10.4%) |
| June 2004 | - | 76.40%(-15.3%) |
| Mar 2004 | - | 90.18%(+1.3%) |
| Dec 2003 | 86.19%(-6.9%) | 89.05%(+2.3%) |
| Sept 2003 | - | 87.06%(+0.5%) |
| June 2003 | - | 86.64%(+5.8%) |
| Mar 2003 | - | 81.89%(-12.2%) |
| Dec 2002 | 92.60%(-2.1%) | 93.30%(+1.8%) |
| Sept 2002 | - | 91.64%(-0.9%) |
| June 2002 | - | 92.48%(-0.5%) |
| Mar 2002 | - | 92.93%(+2.2%) |
| Dec 2001 | 94.62%(-19.4%) | 90.94%(-0.3%) |
| Sept 2001 | - | 91.17%(-88.9%) |
| Dec 1996 | 117.39%(-11.3%) | - |
| Dec 1995 | 132.35%(+2.3%) | - |
| Dec 1994 | 129.41% | 820.00%(-1084.0%) |
| Sept 1994 | - | -83.33%(-64.3%) |
| June 1994 | - | -233.33%(+55.6%) |
| Mar 1994 | - | -150.00% |
FAQ
- What is Nektar Therapeutics annual gross profit margin?
- What is the all time high annual gross margin for Nektar Therapeutics?
- What is Nektar Therapeutics annual gross margin year-on-year change?
- What is Nektar Therapeutics quarterly gross profit margin?
- What is the all time high quarterly gross margin for Nektar Therapeutics?
- What is Nektar Therapeutics quarterly gross margin year-on-year change?
What is Nektar Therapeutics annual gross profit margin?
The current annual gross margin of NKTR is 62.53%
What is the all time high annual gross margin for Nektar Therapeutics?
Nektar Therapeutics all-time high annual gross profit margin is 132.35%
What is Nektar Therapeutics annual gross margin year-on-year change?
Over the past year, NKTR annual gross profit margin has changed by -13.97% (-18.26%)
What is Nektar Therapeutics quarterly gross profit margin?
The current quarterly gross margin of NKTR is 81.62%
What is the all time high quarterly gross margin for Nektar Therapeutics?
Nektar Therapeutics all-time high quarterly gross profit margin is 820.00%
What is Nektar Therapeutics quarterly gross margin year-on-year change?
Over the past year, NKTR quarterly gross profit margin has changed by +33.11% (+68.25%)